Chapter 1: Healthcare Compliance Programs: From Murky Beginnings to Established Expectation

Printer Friendly, PDF & Email

Healthcare Compliance Programs: From Murky Beginnings to Established Expectation

 
1Seth Whitelaw is President & CEO of Whitelaw Compliance Group LLC; Senior Fellow & Adjunct Professor, Life Science Compliance, Mitchell Hamline School of Law; Editor, Policy & Medicine Compliance Update. With more than 30 years working in the life sciences industry, Dr. Whitelaw started his career in life science compliance in 1993, when he became the compliance coordinator for C.R. Bard Inc. Present since the inception of life science compliance, his career has encompassed a wide variety of roles such as in-house compliance officer with C.R. Bard Inc., SmithKline Beecham NA, GlaxoSmithKline, and Misonix Inc.; industry consultant with Deloitte and his own firm; editor of a widely read industry compliance publication; and a law professor where he currently teaches students about healthcare compliance.